| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |